BBIO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Jun 2024 @ 00:27):
Our systems believe the stock currently is overvalued by -0.09% compare to its pairs and should correct downwards.

Stats
今日成交量	1.01M
平均成交量	1.85M
市值	4.54B
EPS	$-0.200 ( Q1 \| 2024-05-02 )
下一个收益日期	( $-1.090 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.50 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0720 (0.30%)

AADI -3.52%

ABCL 2.20%

ABCM 0.04%

ABEO -2.14%

ABIO -1.68%

ABOS 0.70%

ABSI 1.53%

ABUS -1.64%

ABVX -1.50%

ACAD -0.58%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -4.11%

ACHV 0.00%

ACIU -0.75%

ACLX 0.95%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.54%

ADGI 0.87%

ADIL 1.75%

ADMA -2.13%

ADPT 0.00%

ADTX -2.08%

ADVM -3.33%

ADXN -1.60%

AEON -4.50%

AEZS -2.49%

AFMD -1.60%

AGEN -2.72%

AGIO -2.25%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 0.02%

AKRO -3.28%

AKTX 1.05%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.57%

ALGS -0.74%

ALKS 0.50%

ALLK -10.13%

ALLO -6.04%

ALLR -0.58%

ALNA 3.16%

ALNY 2.48%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.38%

ALVR 2.98%

ALXN 0.00%

ALXO -13.09%

ALZN 5.27%

AMRN -1.13%

AMTI -3.13%

ANAB 1.09%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.11%

ANPC -3.15%

APGE -0.72%

APGN 8.48%

APGNW 30.65%

APLM -2.32%

APLS 0.32%

APLT -3.15%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.02%

ARDS -14.23%

ARDX 0.17%

ARGX -0.90%

ARNA 0.00%

ARPO -0.90%

ARQT -0.31%

ARTL -2.50%

ARTLW 0.00%

ARVN 4.99%

ARWR -1.08%

ASLN -3.88%

ASMB -5.81%

ASND -1.79%

ATAI -1.85%

ATHA 5.39%

ATHE 0.56%

ATHX -33.50%

ATNF 4.32%

ATOS 0.97%

ATRA -1.93%

ATXI -2.78%

ATXS -0.11%

AUPH -0.99%

AURA 2.79%

AUTL -1.29%

AVBP -3.32%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.48%

AVTX -1.25%

AVXL -4.05%

AXLA 0.00%

AXSM -1.15%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 3.68%

BCAB 5.23%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.83%

BCRX 0.33%

BCTX 8.90%

BCTXW -16.32%

BCYC 0.75%

BDRX -4.64%

BDTX -1.81%

BEAM 1.03%

BFRA -2.91%

BGNE -2.40%

BIOR -6.15%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE 0.33%

BMEA -11.36%

BMRN 0.25%

BNOX 6.22%

BNTC -0.42%

BNTX -1.58%

BOLD -12.19%

BOLT -1.24%

BPMC -0.85%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 25.55%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.59%

CADL -1.95%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 12.99%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.67%

CCCC -5.73%

CCXI 0.00%

CDAK 0.00%

CDIO -2.18%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -7.72%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.20%

CDXS 7.06%

CELC -4.37%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.21%

CERO -3.45%

CEROW -21.56%

CFRX -27.95%

CGEM -3.17%

CGEN -3.05%

CGON -1.78%

CGTX -3.98%

CHMA -6.00%

CHRS 1.27%

CINC 0.00%

CING -0.63%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -1.33%

CLGN 0.34%

CLLS -4.15%

CLNN 2.43%

CLNNW 0.00%

CLRB 6.27%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -1.42%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.47%

CNCE 0.00%

CNSP -36.62%

CNST 0.00%

CNTA -0.45%

CNTB 0.00%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -2.88%

CORT 2.75%

COYA -1.46%

CPRX -1.06%

CRBP -3.43%

CRBU -5.98%

CRDF -1.11%

CRGX -0.13%

CRIS -1.72%

CRNX -5.85%

CRSP 0.46%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -4.13%

CTNM -2.11%

CTXR 2.42%

CUE 6.57%

CVAC -4.94%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.46%

CYTO -1.83%

DARE 4.02%

DAWN -0.86%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.71%

DNLI -1.56%

DNTH -9.98%

DOMH 2.43%

DRMA -1.68%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.72%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 5.89%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -5.81%

ELOX -5.38%

ELTX -0.88%

ELVN -3.87%

ELYM 2.23%

ENGN -1.72%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 1.58%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.34%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.72%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -2.42%

ETON 1.82%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.40%

EXAI -1.32%

EXEL 0.11%

EYEG -0.69%

EYEN 1.42%

EYPT 0.61%

FATE -9.68%

FBIO 0.85%

FBIOP -0.37%

FBLG -14.69%

FBRX -0.02%

FDMT -3.50%

FENC -1.29%

FGEN -7.27%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.98%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.36%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -5.36%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.54%

GHRS -2.30%

GLMD -5.09%

GLPG -2.15%

GLSI 1.43%

GLTO -2.16%

GLUE -2.37%

GLYC -10.15%

GMAB -0.23%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -10.28%

GOVX 0.91%

GOVXW -49.04%

GPCR -8.55%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.18%

GRTX 5.14%

GTHX 0.23%

GUTS -5.08%

GXGXW 41.67%

GYRE -8.47%

HALO -1.14%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 2.83%

HOTH -3.51%

HOWL -2.35%

HRMY 1.91%

HRTX 3.77%

HSTO 0.00%

HUMA 0.71%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 19.15%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.83%

IFRX -1.54%

IGMS -0.29%

IKNA 0.89%

IKT 0.70%

IMAB 2.03%

IMCR -2.96%

IMGN 0.02%

IMGO 0.00%

IMMP 4.75%

IMMX -7.76%

IMNM 1.00%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -0.75%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -4.73%

INAB -0.56%

INBX 0.76%

INCY -1.28%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.14%

INMB 1.68%

INO -1.30%

INSM -1.28%

INTS -2.75%

INVA 0.56%

INZY 0.69%

IOBT -11.11%

IONS 0.74%

IOVA -3.02%

IPA -0.49%

IPHA 5.58%

IPSC -2.34%

IRON -1.64%

ISEE 0.38%

ITOS -1.71%

ITRM 1.67%

IVA 6.96%

IVVD -2.48%

JAGX 0.79%

JANX -3.64%

JAZZ -0.47%

JNCE 0.00%

JSPR -5.85%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -5.37%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -6.13%

KPRX 0.96%

KPTI -4.61%

KRBP -10.00%

KRON 0.58%

KROS -1.10%

KRRO -8.11%

KRTX 0.03%

KRYS -0.25%

KTRA 9.06%

KTTA -6.79%

KTTAW 0.92%

KURA -0.29%

KYMR -3.14%

KYTX -4.13%

KZIA 2.65%

KZR -0.85%

LABP 0.57%

LBPH -1.18%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -4.83%

LEXX 0.78%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.71%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.22%

LPCN -1.86%

LPTX -2.72%

LQDA -0.16%

LRMR -1.56%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -2.79%

LXRX -2.06%

LYEL -36.03%

LYRA 1.16%

MACK 0.10%

MBIO -10.02%

MBRX -1.72%

MCRB 3.17%

MDGL -0.99%

MDNA -13.16%

MDWD -0.34%

MDXG -2.80%

MEIP 1.40%

MESO -1.41%

MGNX -2.56%

MGTA -7.74%

MGTX -3.57%

MGX -4.01%

MIRM -1.18%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.71%

MLYS -7.52%

MNKD 0.29%

MNMD -0.07%

MNOV 2.11%

MNPR -8.52%

MOLN 1.79%

MOR 1.20%

MORF -3.40%

MREO -2.71%

MRKR 2.57%

MRNA -5.88%

MRNS -4.04%

MRSN -2.38%

MRTX -0.17%

MRUS 0.24%

MRVI -1.16%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 5.46%

NAMS 2.94%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.59%

NKGN 10.14%

NKGNW 8.00%

NKTR -4.21%

NKTX -5.38%

NLSP 5.35%

NLSPW 26.67%

NMRA -3.09%

NMTR -42.97%

NOVN -24.84%

NRBO 9.47%

NRIX -2.14%

NRSN -5.12%

NRSNW 0.00%

NRXP -3.75%

NRXPW 18.33%

NRXS 4.82%

NTBL 3.42%

NTEC -12.45%

NTHI 0.00%

NTLA -6.92%

NTRBW -31.07%

NUVL -1.69%

NVAX -2.50%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.45%

OABIW -10.06%

OBIO -3.07%

OBSV 0.00%

OCEA 0.00%

OCGN 2.97%

OCS -1.00%

OCUL -0.08%

OCUP 1.84%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.03%

OMGA 5.42%

ONCO 4.54%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 1.49%

ONTX -0.47%

ONVO 0.47%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.41%

ORMP 19.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.22%

OVID 0.28%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -3.48%

PBYI 1.52%

PCSA 0.00%

PCVX -0.23%

PDSB -4.58%

PEPG 0.78%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -0.83%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.47%

PLUR 7.39%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -5.61%

PRAX 3.19%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.00%

PRQR -0.66%

PRTA -2.31%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.45%

PSTX -1.36%

PTCT -0.51%

PTE -0.82%

PTGX -0.91%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 1.14%

QLGN -3.00%

QNCX 5.70%

QNRX -1.34%

QSI -11.59%

QSIAW -3.13%

QTTB -3.45%

QURE -0.79%

RAIN -1.63%

RANI 6.42%

RAPT -0.97%

RARE 1.27%

RCKT -8.68%

REGN 0.17%

RENB -3.41%

REPL -2.15%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 4.38%

RGLS -6.78%

RGNX -5.56%

RIGL -3.28%

RLAY -3.56%

RLMD 0.35%

RLYB -1.01%

RNA 0.51%

RNAC -2.94%

RNAZ -1.90%

RNXT 0.89%

ROIV -1.99%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.28%

RPTX 0.15%

RUBY 2.70%

RVLP -32.05%

RVMD -0.90%

RVMDW -30.00%

RVNC 0.00%

RVPH -2.38%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.90%

RYTM -5.19%

RYZB 0.02%

RZLT 3.93%

SABS -1.37%

SABSW -11.81%

SAGE 1.19%

SANA -3.69%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.30%

SCPS 0.00%

SEEL -4.12%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.30%

SGMT -2.18%

SGTX -2.56%

SIOX 22.63%

SLDB -9.47%

SLGL 4.12%

SLN -4.57%

SLNO -4.39%

SLRX 5.26%

SLS -1.71%

SMMT -1.75%

SNDX 1.33%

SNGX -4.91%

SNPX -4.44%

SONN -0.01%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -0.91%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -5.66%

STRO -3.85%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -7.76%

SWTX -0.54%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.14%

TARS 0.45%

TBPH 0.60%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.05%

TECH -0.21%

TENX 1.91%

TERN -8.13%

TFFP -5.33%

TGTX -4.39%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.13%

TNXP -6.00%

TNYA -4.91%

TPST 4.86%

TRDA -4.06%

TRVI 2.30%

TRVN 6.50%

TSHA -22.45%

TSVT -2.93%

TTNP -7.66%

TVTX 1.13%

TYRA -8.54%

UBX -2.48%

UNCY -4.00%

URGN -1.15%

UTHR 0.61%

VACC 11.36%

VALN -4.07%

VAXX 100.00%

VBIV 0.33%

VBLT -8.77%

VCEL 0.74%

VCNX 10.35%

VCYT -1.34%

VERA -3.92%

VERU 0.98%

VERV -2.96%

VIGL 4.84%

VINC 2.28%

VIR 1.08%

VIRI -1.85%

VIRX 3.15%

VKTX -1.23%

VLON -13.04%

VNDA -3.50%

VOR -2.41%

VRCA -0.28%

VRDN -4.51%

VRNA -0.80%

VRPX 0.38%

VRTX 0.32%

VSTM -1.19%

VTGN -0.45%

VTVT -2.97%

VTYX -1.05%

VXRT -4.38%

VYGR -0.38%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.19%

XBIO 1.03%

XBIT -2.92%

XCUR 3.55%

XENE -1.38%

XERS 2.62%

XFOR 4.69%

XLO 3.94%

XLRN 0.00%

XNCR 0.52%

XOMA -2.85%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.65%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-21	Valantine Hannah	Buy	26 014	Stock Option (Right to Buy)
2024-06-21	Scott Randal W.	Buy	26 014	Stock Option (Right to Buy)
2024-06-21	Satvat Ali J.	Buy	26 014	Stock Option (Right to Buy)
2024-06-21	Momtazee James C	Buy	26 014	Stock Option (Right to Buy)
2024-06-21	Hassan Fred	Buy	26 014	Stock Option (Right to Buy)

INSIDER POWER
23.96
Last 100 transactions
Buy: 1 273 661 \| Sell: 882 140

相关性 (AI algo v.1.1b): Overvalued: -0.09% $24.22 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: 0.28 (neutral)

短: -0.72 (moderate negative)

Signal:(53.148) Neutral

BridgeBio Pharma Inc 相关性

10 最正相关
OZEM	1
RRGB	0.93
LPSN	0.927
AMPH	0.924
NARI	0.919
SPTN	0.919
COMM	0.918
CNXC	0.915
SMSI	0.915
QNRX	0.914

10 最负相关
MTEK	-0.903
KINS	-0.901
JVA	-0.896
ASMB	-0.896
VNOM	-0.892
BWMX	-0.89
CDRO	-0.888
NATL	-0.888
ARYD	-0.887
FANG	-0.883

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

BridgeBio Pharma Inc 相关性 - 货币/商品

0.41
( neutral )

0.75
( moderate )

0.00
( neutral )

-0.86
( strong negative )

0.82
( strong )

-0.68
( moderate negative )

BridgeBio Pharma Inc 财务报表

Annual	2023
营收:	$9.30M
毛利润:	$6.86M (73.71 %)
EPS:	$-3.95

FY	2023
营收:	$9.30M
毛利润:	$6.86M (73.71 %)
EPS:	$-3.95

FY	2022
营收:	$77.65M
毛利润:	$74.21M (95.58 %)
EPS:	$-3.35

FY	2021
营收:	$69.72M
毛利润:	$66.60M (95.53 %)
EPS:	$-4.77

Financial Reports:

No articles found.

BridgeBio Pharma Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BridgeBio Pharma Inc

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-cardiomyopathy, or ATTR-CM; BBP-831, a small molecule selective FGFR1-3 inhibitor, which is Phase 2 clinical trial to treat achondroplasia in pediatric patients; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 2 proof-of-concept clinical trial for Autosomal Dominant Hypocalcemia Type 1, or ADH1; and BBP-711 for the treatment of hyperoxaluria, as well as patients suffering from recurrent kidney stones. In addition, it engages in developing products for Mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and The Regents of the University of California; Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.